A phase I study of LOXO-292, a highly selective RET inhibitor, in pediatric patients with RET-altered cancers Meeting Abstract
| Authors: | DuBois, S. G.; Albert, C. M.; Mascarenhas, L.; Laetsch, T. W.; van Tilburg, C. M.; Potter, S. L.; Turpin, B.; Bender, J. L. G.; Spunt, S. L.; Hladun, R.; Casanova, M.; Ziegler, D. S.; Morgenstern, D. A.; Eary, T.; Ibabekci, S.; Qamoos, H.; Rothenberg, S. M.; Cox, M. C.; Balis, F. M.; Pappo, A. S. |
| Abstract Title: | A phase I study of LOXO-292, a highly selective RET inhibitor, in pediatric patients with RET-altered cancers |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 550s |
| Language: | English |
| ACCESSION: | WOS:000487345803218 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS10066 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS10066 -- Source: Wos |
